HAMBURG, Germany and OXFORD, UK, February 16 /PRNewswire-FirstCall/ -- Evotec AG is going to hold an R&D Update in London on 19 February 2007 at 02.30 pm GMT (03.30 pm CET, 09.30 am EST) which will be broadcast live on the internet.
Jorn Aldag (President & Chief Executive Officer), Dr John Kemp (Chief Research & Development Officer) and Dr Tim Tasker (Executive Vice President Clinical Development) will give you an update on the current status and future development plans of our clinical programmes as well as on our discovery pipeline.
To join the audio webcast and to access the presentation slides you will find a link on our home page www.evotec.com shortly before the event.
For those who prefer to listen to the presentation via phone, please dial: From Europe: +49-(0)69-2222-3105 (Germany) +44-(0)20-7138-0827 (UK) From the US: +1-718-354-1358
The on-demand version of the webcast will be available on our website: www.evotec.com - Investors - Webcasts.
Contact: Evotec AG Anne Hennecke SVP, Investor Relations & Corporate Communications Phone: +49-(0)40-56081-286 Fax: +49.(0)40.56081-333 E-Mail: anne.hennecke@evotec.com
Evotec AG
CONTACT: Contact: Evotec AG, Anne Hennecke, SVP, Investor Relations &Corporate Communications, Phone: +49-(0)40-56081-286, Fax:+49.(0)40.56081-333, E-Mail: anne.hennecke@evotec.com
